1-methyl-4-phenylpyridinium has been researched along with Aging in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.11) | 18.7374 |
| 1990's | 8 (44.44) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 7 (38.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, K; Imanishi, T; Iwasaki, A; Kashi, T; Kataoka, Y; Mita, Y; Miyasaka, T; Noguchi, N; Saito, Y | 1 |
| Alarcón-Aguilar, A; Königsberg, M; López-Diazguerrero, NE; Luna-López, A | 1 |
| Kao, YH; Lin, CJ; Lu, YH; Peng, YH; Tsai, TF; Wu, KC; Yang, HT | 1 |
| Borrajo, A; Diaz-Ruiz, C; Garrido-Gil, P; Labandeira-Garcia, JL; Rodriguez-Perez, AI | 1 |
| Chung, KC; Darnell, RB; Hwang, IY; Hwang, JY; Kang, HW; Kim, K; Kim, S; Lee, J; Oh, CK; Oh, YJ; Park, HC; Park, WY; Shin, JH; Um, HD; Um, JW | 1 |
| Liu, J; Liu, JQ; Liu, L; Ma, L; Ma, QY; Wang, MW; Wang, YY | 1 |
| Alarcón-Aguilar, A; González-Puertos, VY; Königsberg, M; López-Macay, A; Luna-López, A; Morán, J; Santamaría, A | 1 |
| Cano, J; Machado, A; Santiago, M | 1 |
| Singer, TP; Tipton, KF | 1 |
| Ali, SF; Freyaldenhoven, TE; Hart, RW | 1 |
| Ali, SF; Desai, VG; Feuers, RJ; Hart, RW | 1 |
| Asada, H; Barone, TA; Kaseloo, PA; Lis, A; Plunkett, RJ | 1 |
| Azevedo, I; Calhau, C; Hipólito-Reis, C; Martel, F; Martins, MJ | 1 |
| Di Monte, DA; Quik, M | 1 |
| Kondo, T; Mizuno, Y; Nakagawa-Hattori, Y; Yoshino, H | 1 |
| Delanney, LE; Di Monte, D; Finnegan, KT; Irwin, I; Langston, JW | 1 |
| DeLanney, LE; Irwin, I; Langston, JW; Ricaurte, GA | 1 |
| DeLanney, LE; Irwin, I; Langston, JW | 1 |
1 review(s) available for 1-methyl-4-phenylpyridinium and Aging
| Article | Year |
|---|---|
Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Aging; Animals; Biological Transport; Humans; Mitochondria; Nervous System; Oxidation-Reduction; Parkinson Disease; Selegiline; Species Specificity | 1993 |
17 other study(ies) available for 1-methyl-4-phenylpyridinium and Aging
| Article | Year |
|---|---|
Distribution of oxidized DJ-1 in Parkinson's disease-related sites in the brain and in the peripheral tissues: effects of aging and a neurotoxin.
Topics: 1-Methyl-4-phenylpyridinium; Age Factors; Aging; Animals; Brain; Disease Models, Animal; Dopamine; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Monoamine Oxidase; MPTP Poisoning; Muscle, Skeletal; Myocardium; Neurotoxins; Oxidation-Reduction; Protein Deglycase DJ-1 | 2018 |
The Effect of MPP+ on the Viability of Primary Cortical Astrocytes Isolated from Female and Male Wistar Rats of Different Ages.
Topics: 1-Methyl-4-phenylpyridinium; Aging; Animals; Astrocytes; Cell Separation; Cell Survival; Cells, Cultured; Cerebral Cortex; Female; Hydrogen Peroxide; Male; Rats, Wistar | 2019 |
Decreased expression of organic cation transporters, Oct1 and Oct2, in brain microvessels and its implication to MPTP-induced dopaminergic toxicity in aged mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Aging; Animals; Blood-Brain Barrier; Brain; Corpus Striatum; Dogs; Dopamine; Dose-Response Relationship, Drug; Down-Regulation; Injections, Intraperitoneal; Madin Darby Canine Kidney Cells; Male; Mice, Inbred C57BL; Mice, Knockout; Microdialysis; Microvessels; MPTP Poisoning; Octamer Transcription Factor-1; Organic Cation Transport Proteins; Organic Cation Transporter 2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transfection | 2015 |
Crosstalk between insulin-like growth factor-1 and angiotensin-II in dopaminergic neurons and glial cells: role in neuroinflammation and aging.
Topics: 1-Methyl-4-phenylpyridinium; Age Factors; Aging; Angiotensin II; Animals; Apoptosis; Cells, Cultured; Dopaminergic Neurons; Fluorescent Antibody Technique; Humans; Immunohistochemistry; Inflammation; Injections, Intraventricular; Insulin-Like Growth Factor I; Microglia; Neurodegenerative Diseases; Oxidative Stress; Primary Cell Culture; Rats; Receptor, Angiotensin, Type 1; Receptor, IGF Type 1; Renin-Angiotensin System; Substantia Nigra | 2016 |
Proteolytic degradation and potential role of onconeural protein cdr2 in neurodegeneration.
Topics: 1-Methyl-4-phenylpyridinium; Aging; Animals; Calpain; Cell Death; Cell Line; Disease Models, Animal; Dopaminergic Neurons; Down-Regulation; Mesencephalon; Nerve Degeneration; Nerve Tissue Proteins; Neuroprotection; Parkinson Disease; Postmortem Changes; Proteolysis; Rats, Sprague-Dawley; Substantia Nigra; Tyrosine 3-Monooxygenase; Ubiquitin | 2016 |
[Neurotoxicity effect of MPP+ on primary cultured mesencephalon neurons of SAMP8 mouse].
Topics: 1-Methyl-4-phenylpyridinium; Aging; Animals; Cells, Cultured; Disease Models, Animal; Female; Male; Mesencephalon; Mice; Mice, Inbred AKR; Neurons; Tyrosine 3-Monooxygenase | 2010 |
Comparing the effects of two neurotoxins in cortical astrocytes obtained from rats of different ages: involvement of oxidative damage.
Topics: 1-Methyl-4-phenylpyridinium; Aging; Amyloid beta-Peptides; Animals; Astrocytes; Brain; Cell Survival; Dose-Response Relationship, Drug; Lipid Peroxidation; Mitochondria; Neurotoxins; Oxidative Stress; Rats; Rats, Wistar | 2014 |
Effects of age and dopamine agonists and antagonists on striatal dopamine release in the rat: an in vivo microdialysis study.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dialysis; Dopamine; Dopamine Agents; Dopamine Antagonists; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Rats; Rats, Wistar | 1993 |
MPTP- and MPP(+)-induced effects on body temperature exhibit age- and strain-dependence in mice.
Topics: 1-Methyl-4-phenylpyridinium; Aging; Analysis of Variance; Animals; Body Temperature Regulation; Dopamine Agents; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Selegiline; Species Specificity | 1995 |
MPP(+)-induced neurotoxicity in mouse is age-dependent: evidenced by the selective inhibition of complexes of electron transport.
Topics: 1-Methyl-4-phenylpyridinium; Aging; Animals; Brain; Dopamine Agents; Electron Transport; Electron Transport Complex IV; Male; Mice; Mice, Inbred C57BL; Mitochondria; NAD(P)H Dehydrogenase (Quinone); Nervous System Diseases | 1996 |
In vitro assessment of neurotrophic activity from the striatum of aging rats.
Topics: 1-Methyl-4-phenylpyridinium; Aging; Animals; Cell Extracts; Cell Line; Cells, Cultured; Chick Embryo; Ciliary Body; Craniocerebral Trauma; Disease Models, Animal; Dopamine Agents; Female; Ganglia, Spinal; Neostriatum; Nerve Growth Factors; Nerve Regeneration; Neurites; Neurons; Oxidopamine; Rats; Rats, Sprague-Dawley; Sympatholytics | 1996 |
Postnatal development of organic cation transport in the rat liver.
Topics: 1-Methyl-4-phenylpyridinium; Aging; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cations; Female; Ion Transport; Liver; Male; Proteins; Rats; Rats, Wistar; Sorbitol; Water | 1998 |
Nicotine administration reduces striatal MPP+ levels in mice.
Topics: 1-Methyl-4-phenylpyridinium; Aging; Animals; Corpus Striatum; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Nicotine; Nicotinic Agonists; Time Factors | 2001 |
Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Adult; Aged; Aged, 80 and over; Aging; Blood Platelets; Dopamine Agents; Female; Humans; Ketoglutarate Dehydrogenase Complex; Lymphocytes; Male; Middle Aged; Mitochondria; NAD(P)H Dehydrogenase (Quinone); NADH Dehydrogenase; Parkinson Disease | 1992 |
The relationships between aging, monoamine oxidase, striatal dopamine and the effects of MPTP in C57BL/6 mice: a critical reassessment.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Aging; Animals; Corpus Striatum; Dopamine; Injections, Intraventricular; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase | 1992 |
The sensitivity of nigrostriatal dopamine neurons to MPP+ does not increase with age.
Topics: 1-Methyl-4-phenylpyridinium; Aging; Animals; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Injections, Intraventricular; Male; Mice; Mice, Inbred C57BL; Pyridinium Compounds; Substantia Nigra | 1988 |
The biotransformation of MPTP and disposition of MPP+: the effects of aging.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Aging; Animals; Biotransformation; Brain; Cerebral Cortex; Corpus Striatum; In Vitro Techniques; Male; Mesencephalon; Mice; Pyridines; Pyridinium Compounds | 1987 |